Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma: A prospective single-center phase II study

The optimal treatment strategy of newly diagnosed stage I/II, extranodal nasal-type natural killer/T cell lymphoma (NKTCL) remains unclear. This prospective phase II trial was conducted to explore the short-term and the long-term efficacy and safety of upfront concurrent chemoradiotherapy (CCRT) fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Fang, Liu, Tao, Pan, Huaxiong, Xiao, Yin, Li, Qiuhui, Liu, Xinxiu, Chen, Wangbing, Wu, Gang, Zhang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437833/
https://www.ncbi.nlm.nih.gov/pubmed/32872045
http://dx.doi.org/10.1097/MD.0000000000021705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437833/
https://www.ncbi.nlm.nih.gov/pubmed/32872045
http://dx.doi.org/10.1097/MD.0000000000021705

Ejemplares similares